Print

Opexa Therapeutics (OPXA)'s Stem Cell Technology Acquired by Novartis Corporation (NVS) (JOBS) in $50 Million Deal  
8/7/2009 6:26:17 AM

Bookmark and Share

Reuters -- Opexa Therapeutics Inc said Swiss drug-maker Novartis has acquired its stem cell technology, which was in early preclinical development, sending its shares up 70 percent before the bell.

//-->